Sasivimol Rattanasiri

Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results

Weerawat Manosuthi, Sasisopin Kiertiburanakul, Somnuek Sungkanuparph et al. · AIDS · 2005 · 108 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +13

Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin

Weerawat Manosuthi, Somnuek Sungkanuparph, Ammarin Thakkinstian et al. · AIDS · 2005 · 84 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Alcohol, illicit and non-illicit psychoactive drug use and road traffic injury in Thailand: A case-control study

Patarawan Woratanarat, Atiporn Ingsathit, Paibul Suriyawongpaisal et al. · Accident Analysis & Prevention · 2009 · 68 citations

Public Health, Injury Prevention, Substance Use Disorders +14

Plasma Nevirapine Levels and 24‐Week Efficacy in HIV‐Infected Patients Receiving Nevirapine‐Based Highly Active Antiretroviral Therapy with or without Rifampicin

Weerawat Manosuthi, Somnuek Sungkanuparph, Ammarin Thakkinstian et al. · Clinical Infectious Diseases · 2006 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Improving quality of colonoscopy by adding simethicone to sodium phosphate bowel preparation

Sasinee Tongprasert, Abhasnee Sobhonslidsuk, Sasivimol Rattanasiri · World Journal of Gastroenterology · 2009 · 60 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15